ProfileGDS4718 / 220892_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 51% 51% 50% 59% 52% 72% 68% 59% 52% 56% 55% 43% 64% 70% 76% 57% 54% 69% 69% 50% 58% 57% 57% 54% 54% 70% 52% 62% 55% 70% 70% 63% 52% 56% 54% 68% 70% 54% 58% 56% 54% 64% 54% 68% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.5421751
GSM549102patient 115, normal, homogenized [OPG study]5.5926751
GSM549104patient 119, normal, homogenized [OPG study]5.4756250
GSM549108patient 138, normal, homogenized [OPG study]6.0695859
GSM549119patient 077, normal, homogenized [OPG study]5.6479852
GSM549133patient 032, cancer, homogenized [OPG study]7.0791772
GSM549139patient 042, cancer, homogenized [OPG study]6.7358168
GSM549099patient 107, normal, homogenized [OPG study]6.0675459
GSM549109patient 139, normal, homogenized [OPG study]5.6427752
GSM549110patient 046, normal, homogenized [OPG study]5.882556
GSM549114patient 063, normal, homogenized [OPG study]5.7599755
GSM549122patient 082, normal, homogenized [OPG study]5.1352143
GSM549134patient 033, cancer, homogenized [OPG study]6.3675964
GSM549136patient 036, cancer, homogenized [OPG study]6.9388170
GSM549140patient 044, cancer, homogenized [OPG study]7.5362876
GSM549111patient 047, normal, homogenized [OPG study]5.9036357
GSM549113patient 057, normal, homogenized [OPG study]5.7118154
GSM549132patient 031, cancer, homogenized [OPG study]6.7987769
GSM549137patient 038, cancer, homogenized [OPG study]6.779969
GSM549142patient 047, cancer, homogenized [OPG study]5.6341150
GSM549100patient 110, normal, homogenized [OPG study]6.0095258
GSM549107patient 135, normal, homogenized [OPG study]5.9136857
GSM549115patient 068, normal, homogenized [OPG study]5.9069357
GSM549116patient 072, normal, homogenized [OPG study]5.7188754
GSM549120patient 078, normal, homogenized [OPG study]5.7558354
GSM549131patient 030, cancer, homogenized [OPG study]6.9002470
GSM549118patient 074, normal, homogenized [OPG study]5.5969652
GSM549129patient 027, cancer, homogenized [OPG study]6.29662
GSM549123patient 088, normal, homogenized [OPG study]5.8334455
GSM549124patient 006, cancer, homogenized [OPG study]6.8603970
GSM549126patient 015, cancer, homogenized [OPG study]6.8979670
GSM549128patient 025, cancer, homogenized [OPG study]6.3575363
GSM549103patient 117, normal, homogenized [OPG study]5.6936552
GSM549117patient 073, normal, homogenized [OPG study]5.839556
GSM549138patient 041, cancer, homogenized [OPG study]5.7551554
GSM549141patient 045, cancer, homogenized [OPG study]6.7838368
GSM549130patient 028, cancer, homogenized [OPG study]6.8992870
GSM549101patient 111, normal, homogenized [OPG study]5.794454
GSM549105patient 128, normal, homogenized [OPG study]6.0353758
GSM549106patient 134, normal, homogenized [OPG study]5.8445956
GSM549112patient 048, normal, homogenized [OPG study]5.7365754
GSM549125patient 011, cancer, homogenized [OPG study]6.399864
GSM549127patient 024, cancer, homogenized [OPG study]5.7895254
GSM549135patient 035, cancer, homogenized [OPG study]6.7411968